Please login to the form below

Not currently logged in
Email:
Password:

RPSGB promotes excellence In pharmacy research

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The School of Pharmacy will host an Academic Excellence Award in 2008, which is a prestigious programme of PhD studentships offered by the RPSGB.

Nottingham was one of only two UK institutions selected from among 23 applicants, after a judging process involving a panel of distinguished pharmacy academics.

The RPSGB Academic Excellence Awards hope to increase the number of pharmacists who enter and stay in academia as a career by providing funding to enable exceptional pharmacists and pharmacy graduates to undertake PhD training. The scheme promotes the important role played by members of the academic workforce in developing and leading the profession of pharmacy.

The University will host an award for research with the title 'Selective inhibitors for nuclear receptors: an alternative to anti-hormone therapies', supervised by Professor David Heery. This work investigates the mechanisms by which genes are switched on or off in healthy or diseased human cells.

The award is only the latest accolade for the highly-rated School of Pharmacy. In April this year the School won a Queen's Award for Enterprise in the category of Innovation. Cardiff University was the other institution to be successful in the Academic Excellence Awards for 2008.

20th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics